NCT03392311 Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis Status COMPLETED Phase PHASE1/PHASE2
NCT03392168 Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis Status COMPLETED Phase PHASE1/PHASE2
NCT03384745 A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis Status COMPLETED Phase PHASE2
NCT03381625 Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT03374527 Recirculating Memory T Cells in the Pathogenesis of Psoriatic Arthritis and Cutaneous Psoriasis Status COMPLETED Phase N/A
NCT03361215 Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis Status RECRUITING Phase N/A
NCT03343639 Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT03339089 Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases Status COMPLETED Phase N/A
NCT03337022 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis Status COMPLETED Phase PHASE1
NCT03329885 A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis Status TERMINATED Phase PHASE1/PHASE2
NCT03279978 This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357 Status COMPLETED Phase PHASE1
NCT03265613 Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis Status COMPLETED Phase PHASE1/PHASE2
NCT03262727 The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients Status COMPLETED Phase PHASE1
NCT03255382 A Study to Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic Therapy Status COMPLETED Phase PHASE3